UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proteases as therapeutics

Biochemical journal, 2011-04, Vol.435 (1), p.1-16

2011

Volltextzugriff (PDF)

CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts

The Prostate, 2004-11, Vol.61 (3), p.228-235

2004

Volltextzugriff (PDF)

Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase

The Journal of biological chemistry, 2002-01, Vol.277 (3), p.2160-2168

2002

Volltextzugriff (PDF)

Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family

The FEBS journal, 2007-04, Vol.274 (8), p.2148-2160

2007

Volltextzugriff (PDF)

Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer

Cancer and metastasis reviews, 2003-06, Vol.22 (2-3), p.237-258

2003

Volltextzugriff (PDF)

The Kringle V-protease domain is a fibrinogen binding region within Apo(a)

Thrombosis and haemostasis, 2001-11, Vol.86 (5), p.1229-1237

2001

Volltextzugriff (PDF)

Serpin-resistant mutants of human tissue-type plasminogen activator

Nature (London), 1989-06, Vol.339 (6227), p.721-724

1989

Volltextzugriff (PDF)

Converting Tissue Plasminogen Activator to a Zymogen: A Regulatory Triad of Asp-His-Ser

Science (American Association for the Advancement of Science), 1993-10, Vol.262 (5132), p.419-421

1993

Volltextzugriff (PDF)

Identification of Efficiently Cleaved Substrates for HIV-1 Protease Using a Phage Display Library and Use in Inhibitor Development

Virology (New York, N.Y.), 2000-09, Vol.274 (2), p.391-401

2000

Volltextzugriff (PDF)

Optimal Subsite Occupancy and Design of a Selective Inhibitor of Urokinase

The Journal of biological chemistry, 1997-08, Vol.272 (33), p.20456-20462

1997

Volltextzugriff (PDF)

Revisiting Catalysis by Chymotrypsin Family Serine Proteases Using Peptide Substrates and Inhibitors with Unnatural Main Chains

The Journal of biological chemistry, 1999-08, Vol.274 (34), p.24074-24079

1999

Volltextzugriff (PDF)

Converting Tissue-type Plasminogen Activator into a Zymogen

The Journal of biological chemistry, 1996-11, Vol.271 (46), p.28749-28752

1996

Volltextzugriff (PDF)

Binding of Nonphysiological Protein and Peptide Substrates to Proteases: Differences between Urokinase-Type Plasminogen Activator and Trypsin and Contributions to the Evolution of Regulated Proteolysis

Biochemistry (Easton), 2003-05, Vol.42 (18), p.5395-5402

2003

Volltextzugriff (PDF)

Variants of Tissue-type Plasminogen Activator Which Display Substantially Enhanced Stimulation by Fibrin

The Journal of biological chemistry, 1995-08, Vol.270 (31), p.18319-18322

1995

Volltextzugriff (PDF)

Distinct Mechanisms Contribute to Stringent Substrate Specificity of Tissue-type Plasminogen Activator (∗)

The Journal of biological chemistry, 1996-02, Vol.271 (8), p.4461-4467

1996

Volltextzugriff (PDF)

Variants of Tissue-type Plasminogen Activator That Display Extraordinary Resistance to Inhibition by the Serpin Plasminogen Activator Inhibitor Type 1

The Journal of biological chemistry, 1997-06, Vol.272 (23), p.14580-14585

1997

Volltextzugriff (PDF)

Converting Tissue Type Plasminogen Activator into a Zymogen

The Journal of biological chemistry, 1997-01, Vol.272 (1), p.28-31

1997

Volltextzugriff (PDF)

Variants of Tissue-type Plasminogen Activator with Substantially Enhanced Response and Selectivity toward Fibrin Co-factors (∗)

The Journal of biological chemistry, 1995-10, Vol.270 (40), p.23444-23449

1995

Volltextzugriff (PDF)

Distinct Contributions of Residue 192 to the Specificity of Coagulation and Fibrinolytic Serine Proteases

The Journal of biological chemistry, 1999-03, Vol.274 (11), p.7153-7156

1999

Volltextzugriff (PDF)

Rapid and efficient site-directed mutagenesis by single-tube 'megaprimer' PCR method

Nucleic acids research, 1997-08, Vol.25 (16), p.3371-3372

1997

Volltextzugriff (PDF)

Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules

Thrombosis and haemostasis, 1999-03, Vol.81 (3), p.428-435

1999

Volltextzugriff (PDF)

Identification of a Hydrophobic Exosite on Tissue Type Plasminogen Activator That Modulates Specificity for Plasminogen

The Journal of biological chemistry, 1997-01, Vol.272 (3), p.1811-1816

1997

Volltextzugriff (PDF)

A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent

Circulation (New York, N.Y.), 1997-02, Vol.95 (3), p.715-722

1997

Volltextzugriff (PDF)

Directing Sequence-specific Proteolysis to New Targets

The Journal of biological chemistry, 1998-02, Vol.273 (8), p.4323-4328

1998

Volltextzugriff (PDF)

Substrate Specificity of Tissue Type Plasminogen Activator

The Journal of biological chemistry, 1995-03, Vol.270 (13), p.7558-7562

1995

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(79)
Bücher
(2)

Sprache

Englisch
(80)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Proteases as therapeutics

CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts

Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase

Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family

Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer

The Kringle V-protease domain is a fibrinogen binding region within Apo(a)

Serpin-resistant mutants of human tissue-type plasminogen activator

Converting Tissue Plasminogen Activator to a Zymogen: A Regulatory Triad of Asp-His-Ser

Identification of Efficiently Cleaved Substrates for HIV-1 Protease Using a Phage Display Library and Use in Inhibitor Development

Optimal Subsite Occupancy and Design of a Selective Inhibitor of Urokinase

Revisiting Catalysis by Chymotrypsin Family Serine Proteases Using Peptide Substrates and Inhibitors with Unnatural Main Chains

Converting Tissue-type Plasminogen Activator into a Zymogen

Binding of Nonphysiological Protein and Peptide Substrates to Proteases: Differences between Urokinase-Type Plasminogen Activator and Trypsin and Contributions to the Evolution of Regulated Proteolysis

Variants of Tissue-type Plasminogen Activator Which Display Substantially Enhanced Stimulation by Fibrin

Distinct Mechanisms Contribute to Stringent Substrate Specificity of Tissue-type Plasminogen Activator (∗)

Variants of Tissue-type Plasminogen Activator That Display Extraordinary Resistance to Inhibition by the Serpin Plasminogen Activator Inhibitor Type 1

Converting Tissue Type Plasminogen Activator into a Zymogen

Variants of Tissue-type Plasminogen Activator with Substantially Enhanced Response and Selectivity toward Fibrin Co-factors (∗)

Distinct Contributions of Residue 192 to the Specificity of Coagulation and Fibrinolytic Serine Proteases

Rapid and efficient site-directed mutagenesis by single-tube 'megaprimer' PCR method

Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules

Identification of a Hydrophobic Exosite on Tissue Type Plasminogen Activator That Modulates Specificity for Plasminogen

A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent

Directing Sequence-specific Proteolysis to New Targets

Substrate Specificity of Tissue Type Plasminogen Activator

Suchergebnisse filtern